Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Aytu Biopharma stock in Canada
Own Aytu Biopharma shares in just a few minutes.
Aytu Biopharma is a drug manufacturers-specialty & generic business based in the US. Aytu Biopharma stocks (AYTU.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.54 – an increase of 5.38% over the previous week. Aytu Biopharma employs 175 staff and has a trailing 12-month revenue of around $74 million.
How to buy shares in Aytu Biopharma
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – AYTU – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Aytu Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Aytu Biopharma?
- Has coronavirus impacted Aytu Biopharma shares?
- Aytu Biopharma shares summary
- Compare share dealing platforms
- Is Aytu Biopharma stock a buy or sell?
- Aytu Biopharma performance over time
- Aytu Biopharma's financials
- How volatile are Aytu Biopharma shares?
- Does Aytu Biopharma pay a dividend?
- Have Aytu Biopharma shares ever split?
- Other common questions
How has Coronavirus impacted Aytu Biopharma's stock price?
Since the stock market crash in March caused by coronavirus, Aytu Biopharma's stock price has had significant positive movement.
Its last market close was $1.96, which is 61.58% up on its pre-crash value of $0.753 and 484.73% up on the lowest point reached during the March crash when the stocks fell as low as $0.3352.
If you had bought $1,000 worth of Aytu Biopharma stocks at the start of February 2020, those stocks would have been worth $2,630.10 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $2,756.68.
Aytu Biopharma stock price (NASDAQ: AYTU)Use our graph to track the performance of AYTU stocks over time.
Aytu Biopharma shares at a glance
|Latest market close||$1.96|
|52-week range||$1.80 - $11.76|
|50-day moving average||$2.56|
|200-day moving average||$4.90|
|Wall St. target price||$17.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-4.07|
Compare online trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Aytu Biopharma price performance over time
|1 week (2021-11-23)||5.38%|
|1 month (2021-10-28)||N/A|
|3 months (2021-09-01)||-48.83%|
|6 months (2021-05-28)||N/A|
|1 year (2020-12-01)||126.59%|
|2 years (2019-11-29)||133.67%|
|3 years (2018-11-30)||94.06%|
|5 years (2016-11-30)||64.71%|
Aytu Biopharma financials
|Revenue TTM||$74 million|
|Gross profit TTM||$29.2 million|
|Return on assets TTM||-14.54%|
|Return on equity TTM||-80.8%|
|Market capitalisation||$55.2 million|
TTM: trailing 12 months
Aytu Biopharma share dividends
We're not expecting Aytu Biopharma to pay a dividend over the next 12 months.
Have Aytu Biopharma's shares ever split?
Aytu Biopharma's shares were split on a 1:10 basis on 9 December 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aytu Biopharma shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aytu Biopharma shares which in turn could have impacted Aytu Biopharma's share price.
Aytu Biopharma share price volatility
Over the last 12 months, Aytu Biopharma's shares have ranged in value from as little as $1.8 up to $11.76. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aytu Biopharma's is -0.346. This would suggest that Aytu Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Aytu Biopharma has bucked the trend.
Aytu Biopharma overview
Aytu Biopharma, Inc. , a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021.
Stocks similar to Aytu Biopharma
Frequently asked questions
Aytu Biopharma in the news
Why AT&T Stock Dropped Today
Kyndryl Holdings Inc Shares Fall 3.1% Below Previous 52-Week Low - Market Mover
Oscar Health Inc - Class A Shares Fall 0.7% Below Previous 52-Week Low - Market Mover
More on investing
We break down how the CRA treats stock gains and losses, how foreign stocks are taxed, which trading expenses are tax-deductible and more.Read more…
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
We look at 6 popular stock discussion groups from Canada and overseas.Read more…
More guides on Finder
How to buy Intensity Therapeutics (INTS) stock in Canada when it goes public
Everything we know about the Intensity Therapeutics IPO, plus information on how to buy in.
How to buy Incannex Healthcare Limited (IXHL) stock in Canada when it goes public
Everything we know about the Incannex Healthcare Limited IPO, plus information on how to buy in.
How to buy Genenta Science SpA (GNTA) stock in Canada when it goes public
Everything we know about the Genenta Science SpA IPO, plus information on how to buy in.
Top trending stocks on Twitter
We’ve pulled a list together of the top trending stocks being mentioned on Twitter over the past 24 hours.
How to buy Polestar (PSNY) stock in Canada when it goes public
Everything we know about the Polestar IPO, plus information on how to buy in.
How to buy Knightscope (KSCP) stock in Canada when it goes public
Everything we know about the Knightscope IPO, plus information on how to buy in.
How to buy Sangoma Technologies Corporation (STC) stock in Canada
Everything we know about the Sangoma Technologies Corporation IPO, plus information on how to buy in.
How to buy Sweetgreen stock in Canada
Everything we know about the Sweetgreen IPO, plus information on how to buy in.
How to buy UserTesting (USER) stock in Canada
Everything we know about the UserTesting IPO, plus information on how to buy in.
How to buy Sono Motors (SEV) stock in Canada
Everything we know about the Sono Motors IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.